Prognosis: Breakthrough

Johnson & Johnson's CEO on the Newest Vaccine

Prognosis: Breakthrough

Now that Johnson & Johnson’s Covid-19 vaccine has been cleared by regulators, the company needs to ramp up doses fast. J and J is looking for manufacturing partnerships to increase supply. Riley Griffin spoke to the company’s chief executive officer, Alex Gorsky about his plan to immunize 20 million Americans by the end of the month, and 100 million by the end of June. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

Can the Arts Recover? @ Prognosis: Breakthrough

πŸ“† 2021-02-26 22:44 / βŒ› 00:12:20


Prognosis: Breakthrough

The Second Shot Squeeze @ Prognosis: Breakthrough

πŸ“† 2021-02-24 21:39 / βŒ› 00:19:25


Prognosis: Breakthrough

How the Vaccines Will Change Our Lives @ Prognosis: Breakthrough

πŸ“† 2021-02-22 21:57 / βŒ› 00:11:12


Prognosis: Breakthrough

The Good Kind of Surge @ Prognosis: Breakthrough

πŸ“† 2021-02-19 20:49 / βŒ› 00:18:22


Prognosis: Breakthrough

Fixing Vaccine Inequity @ Prognosis: Breakthrough

πŸ“† 2021-02-17 22:53 / βŒ› 00:18:01